Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin effects on empathy and mentalising in psychotic and severe personality disorders
2007-006561-32Phase 2Completed
- Sponsor
- LWL University Hospital Bochum
- Start
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of oxytocin in schizophrenia, bipolar disorder (BD), major depressive disorder (MDD) and 1 more (2 arms), sponsored by LWL University Hospital Bochum. Primary endpoint: Improvement of perception and interpretation of emotional stimuli. Started Sep 2009; status: completed.
02
Drugs
oxytocin
03
Conditions
schizophreniabipolar disorder (BD)major depressive disorder (MDD)personality disorder (PD)
Beyond the preview
Go deeper on 2007-006561-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006561-32.